Private Advisor Group’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.76M Buy
94,085
+2,843
+3% +$219K 0.03% 524
2025
Q4
$7.24M Buy
91,242
+3,558
+4% +$280K 0.03% 482
2025
Q3
$6.61M Sell
87,684
-1,073
-1% -$73.5K 0.03% 513
2025
Q2
$6.12M Sell
88,757
-1,210
-1% -$79.3K 0.03% 496
2025
Q1
$6.1M Buy
89,967
+560
+0.6% +$33.5K 0.04% 468
2024
Q4
$4.01M Sell
89,407
-16,454
-16% -$923K 0.02% 595
2024
Q3
$6.66M Sell
105,861
-11,106
-9% -$648K 0.04% 423
2024
Q2
$6.91M Sell
116,967
-6,700
-5% -$419K 0.05% 374
2024
Q1
$9.86M Sell
123,667
-7,767
-6% -$593K 0.07% 261
2023
Q4
$10.4M Sell
131,434
-5,651
-4% -$402K 0.08% 237
2023
Q3
$9.57M Buy
137,085
+11,224
+9% +$795K 0.09% 234
2023
Q2
$8.97M Sell
125,861
-30,561
-20% -$2.17M 0.08% 242
2023
Q1
$11.6M Buy
156,422
+8,088
+5% +$678K 0.11% 190
2022
Q4
$4.17M Buy
148,334
+7,728
+5% +$746K 0.21% 107
2022
Q3
$13.4M Sell
140,606
-48,610
-26% -$4.81M 0.15% 139
2022
Q2
$17.5M Sell
189,216
-20,484
-10% -$2M 0.16% 134
2022
Q1
$21.2M Buy
209,700
+308
+0.1% +$32.4K 0.16% 129
2021
Q4
$21.6M Sell
209,392
-93,843
-31% -$8.67M 0.16% 126
2021
Q3
$25.7M Buy
303,235
+120,669
+66% +$10.1M 0.16% 120
2021
Q2
$15.2M Buy
182,566
+1,860
+1% +$152K 0.13% 160
2021
Q1
$13.6M Sell
180,706
-8,237
-4% -$600K 0.13% 158
2020
Q4
$12.9M Buy
188,943
+64,870
+52% +$4.22M 0.13% 166
2020
Q3
$7.45M Sell
124,073
-3,930
-3% -$245K 0.1% 213
2020
Q2
$8.32M Buy
128,003
+5,741
+5% +$362K 0.12% 186
2020
Q1
$7.25M Buy
122,262
+10,921
+10% +$729K 0.13% 167
2019
Q4
$8.27M Sell
111,341
-24,621
-18% -$1.73M 0.13% 174
2019
Q3
$8.21M Buy
135,962
+28,338
+26% +$1.68M 0.13% 181
2019
Q2
$5.86M Buy
107,624
+45,886
+74% +$2.47M 0.11% 215
2019
Q1
$3.34M Buy
61,738
+19,020
+45% +$1.17M 0.07% 296
2018
Q4
$2.8M Sell
42,718
-1,449
-3% -$108K 0.07% 288
2018
Q3
$3.48M Buy
44,167
+14,751
+50% +$1.05M 0.07% 273
2018
Q2
$1.91M Buy
29,416
+9,487
+48% +$625K 0.03% 288
2018
Q1
$1.24M Sell
19,929
-4,706
-19% -$338K 0.05% 360
2017
Q4
$1.89M Sell
24,635
-19,158
-44% -$1.39M 0.08% 246
2017
Q3
$3.27M Buy
43,793
+6,399
+17% +$506K 0.08% 253
2017
Q2
$2.92M Sell
37,394
-94,946
-72% -$7.5M 0.08% 252
2017
Q1
$7.39M Buy
132,340
+92,431
+232% +$7.38M 0.21% 119
2016
Q4
$3.3M Sell
39,909
-2,841
-7% -$230K 0.11% 197
2016
Q3
$3.69M Sell
42,750
-3,248
-7% -$307K 0.15% 147
2016
Q2
$4.37M Buy
45,998
+10,267
+29% +$1.02M 0.18% 129
2016
Q1
$3.65M Sell
35,731
-810
-2% -$78.8K 0.18% 130
2015
Q4
$3.57M Buy
36,541
+2,449
+7% +$240K 0.17% 134
2015
Q3
$3.29M Sell
34,092
-12,782
-27% -$1.34M 0.18% 124
2015
Q2
$4.92M Buy
46,874
+5,914
+14% +$604K 0.23% 84
2015
Q1
$4.23M Buy
40,960
+9,138
+29% +$925K 0.24% 91
2014
Q4
$3.06M Buy
31,822
+10,075
+46% +$888K 0.2% 119
2014
Q3
$1.73M Buy
21,747
+6,503
+43% +$513K 0.12% 196
2014
Q2
$1.15M Buy
15,244
+6,217
+69% +$470K 0.1% 250
2014
Q1
$676K Buy
9,027
+2,695
+43% +$190K 0.07% 329
2013
Q4
$454K Buy
+6,332
New +$407K 0.05% 416

Other funds holding CVS

Private Advisor Group's CVS Position: Q1 2026 in Review

Private Advisor Group increased its CVS Health (CVS) stake by 3.1% in Q1 2026, buying an estimated $219K and bringing the position to 94,085 shares worth $6.76M. The position accounts for 0.03% of the portfolio, ranked #524.

Private Advisor Group first reported a position in CVS in Q4 2013 and has held it in 50 quarters since. The position peaked at $25.7M in Q3 2021. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Private Advisor Group held 94,085 shares of CVS Health worth $6.76M as of Q1 2026.
  • Private Advisor Group bought 2,843 CVS Health shares in Q1 2026, an estimated $219K.
  • CVS Health made up 0.03% of Private Advisor Group's portfolio in Q1 2026, its #524 holding.
  • Private Advisor Group first reported a position in CVS Health in Q4 2013 and has held it in 50 quarters since.
  • Private Advisor Group's CVS Health position peaked at $25.7M in Q3 2021.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Private Advisor Group's 13F filing for Q1 2026, filed 27 Apr 2026.